1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
CYBERDYNE Inc.

CYBERDYNE Inc.

CYBQY
CYBERDYNE Inc.US flagOther OTC
1.87
USD
- -
- -
333.50MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.62
3.27
6.22
7.76
8.04
7.95
8.33
8.72
9.99
15.32
20.62
20.74
10.44
Basic EPS, GAAP
-3.95
-4.74
-3.53
-3.16
-3.13
-2.94
-0.71
-0.27
-2.31
-1.39
-6.99
-2.73
-4.05
Free Cash Flow per Basic Share
-4.5
-21.99
-8.06
-28.25
-5.48
-7.31
-2.88
-8.6
-10.88
-3.04
-5.09
-3.48
-2.16
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-27.54
-29.56
-31.65
92.79
89.6
87.29
86.59
10.17
7.85
6.48
-0.4
-3.74
-1.81
Tangible Book Value per Share
34.12
143.39
132.82
218.27
211.97
205.22
205.21
203.08
191.99
183.38
181.36
178.76
176.28
Basic Weighted Avg Shares
174
193
203
214
215
215
215
215
215
215
211
211
216
Sales/Revenue/Turnover
456
631
1,265
1,660
1,728
1,709
1,792
1,875
2,150
3,289
4,354
4,384
2,250
Operating Margin (%)
-252.92
-279.77
-102.15
-42.05
-38.19
-48.57
-57.92
-37.33
-40.88
-34.84
-46.35
-21.12
-31.2
Depreciation Expense
180
202
280
335
399
436
492
463
482
627
677
592
353
Net Income, GAAP
-688
-916
-718
-676
-673
-632
-152
-59
-498
-298
-1,476
-577
-874
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
263.74
117.4
- -
841.51
- -
- -
- -
Profit Margin (%)
-150.79
-145.09
-56.77
-40.72
-38.95
-36.98
-8.48
-3.15
-23.16
-9.06
-33.9
-13.16
-38.84
Working Capital
4,791
42,951
20,728
33,838
31,148
29,973
29,081
26,585
22,037
17,856
17,233
15,673
16,065
LT Debt
- -
19,884
- -
- -
- -
- -
364
329
423
433
388
266
303
Total Equity
5,996
27,777
27,064
46,737
45,674
44,203
44,259
43,786
43,450
41,983
40,477
39,593
40,067
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
3.82
0.27
- -
19.61
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-1.68
-0.44
- -
-77.01
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
-3.44
-3.32
-0.81
-0.57
-25.7
-19.35
- -
- -
-329.85

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
244
- -
233
LT Borrowings
22
- -
20
LT Finance Leases
366
- -
283
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
211
- -
211
Market Capitalization
41,568
42,205
38,422

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
18,469
- -
17,233
Cash, Cash Equivalents & STI
16,659
- -
15,630
Accounts Receivable, Net
674
- -
515
Inventories
997
- -
881
Total Current Liabilities
1,236
- -
1,168
Payables & Accruals
- -
- -
- -
ST Debt
244
- -
233
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.38%
-2.2%
-2.18%
Free Cash Flow
28.54%
37.18%
-31.56%
Net Income, GAAP
86.72%
195.42%
-60.91%
Sales/Revenue/Turnover
24.48%
21.07%
0.69%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,045
1,058
1,115
1,135
4,354
2025
- -
- -
- -
- -
4,384
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.56
-4.42
-1.65
- -
-6.99
2025
- -
- -
- -
- -
-2.73
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Yoshiyuki Sankai
Full Time Employees
227
Sector
Healthcare
Industry
Medical - Devices
Address
2-2-1, Gakuen-Minami Tsukuba Japan 305-0818
IPO Date
Jan 8, 2021
Website
cyberdyne.jp
Similar Companies
i-SENS Inc (099190.KS)
Perimeter Medical Imaging AI, Inc. (PYNKF)
INVO Fertility, Inc. (IVF)
Tactile Systems Technology, Inc. (TCMD)
Vicplas International Ltd (569.SI)
Stryker Corporation (0R2S.L)
Business
CYBERDYNE Inc. (Ticker: CYBQY) develops and commercializes cybernic technologies, including wearable robotic devices designed to support human physical functions for rehabilitation, mobility assistance, and daily living. The company offers core products such as the Hybrid Assistive Limb (HAL) series, which utilizes bio-electric signals to power exoskeletons for lower limb support; upper limb HAL for arm rehabilitation; and related services encompassing medical device leasing, training programs for healthcare providers, and custom cybernic system integration. CYBERDYNE operates primarily in the healthcare technology and robotics sectors, targeting hospitals, rehabilitation centers, elderly care facilities, and individual users in Japan, Europe, and select Asian markets; founded in 2004, it maintains headquarters in Tsukuba City, Ibaraki Prefecture, Japan. Recent developments include expanded regulatory approvals for HAL devices in additional European countries as of 2024, enabling broader clinical adoption; a strategic partnership with Japanese healthcare providers to deploy HAL in over 100 facilities nationwide in 2025; and a Series E funding round closed in late 2024 raising approximately ¥5 billion to accelerate R&D in next-generation cybernics for neurodegenerative diseases. The company also launched an upgraded HAL model with enhanced AI-driven motion prediction in early 2025, alongside operational expansions into rental services for industrial applications. No major name changes or reorganizations have occurred recently.

Company News

APIChat